STAT Plus: CVS-Aetna deal further concentrates health care among a few big firms. Will it lower costs?
19:39 EST 3 Dec 2017 |
STAT
Related Biotechnology, Pharmaceutical and Healthcare News
CVS’s deal to buy Aetna, one of the largest health insurers, has the potential for lowering costs, but also further concentrating key services among a few large companies.
Original Article: STAT Plus: CVS-Aetna deal further concentrates health care among a few big firms. Will it lower costs?
NEXT ARTICLE
More From BioPortfolio on "STAT Plus: CVS-Aetna deal further concentrates health care among a few big firms. Will it lower costs?"